1. Tracking the outcomes of surgical treatment of Stage 2 and 3 empyema: introduction and consolidation of minimally invasive approach
- Author
-
Miriam Patella, Iride Porcellini, Adele Tessitore, Eleonora Maddalena Minerva, Agnese Cianfarani, Stefano Cafarotti, University of Zurich, and Patella, Miriam
- Subjects
medicine.medical_specialty ,10255 Clinic for Thoracic Surgery ,medicine.medical_treatment ,610 Medicine & health ,Interquartile range ,medicine ,Humans ,Stage (cooking) ,Surgical treatment ,Empyema, Pleural ,Retrospective Studies ,Thoracic Surgery, Video-Assisted ,business.industry ,Pleural empyema ,General Medicine ,Length of Stay ,medicine.disease ,Empyema ,2746 Surgery ,Surgery ,Chest tube ,Thoracotomy ,Cardiothoracic surgery ,Chest Tubes ,Video-assisted thoracoscopic surgery ,business - Abstract
Background We described the results of surgical treatment of empyema, tracing outcomes throughout the passage from the open thoracotomy (OT) approach to video-assisted thoracoscopic surgery (VATS) in a single institute. Methods We retrospectively analyzed the records of 88 consecutive patients treated for Stage 2 and 3 empyema (2010-2019). We divided the study period into three groups: OT period (2010-2013), early VATS (2014-2017, from the introduction of VATS program, until acme of learning curve), and late VATS (2018-2019). Groups were compared to investigate the outcomes evolution. Results Most relevant findings of the study were significant variation in postoperative length of stay (median [interquartile range]: 9 days [7.5-10], 10 [7.5-17.5], and 7 [5-10] for OT period, early VATS, and late VATS, respectively, p = 0.005), hospital admission referral to thoracic surgery interval (7.5 days [4.5-11], 6.5 [3-9], and 2.5 [1.5-5.5], p = 0.003), chest tube duration (5.5 days [5-7.5], 6 [4-6], 4 [3-5], p = 0.003), and proportion of operation performed by residents (3 [15%], 6 [16.7%], 14 [43.6%], p = 0.01). Conclusions Our findings pictured the trajectory evolution of outcomes during introduction and consolidation of VATS treatment of empyema. During the early phase, we observed a decline in some indicators that improved significantly in the late VATS period. After a learning curve, all outcomes showed better results and we entered into a teaching phase.
- Published
- 2021
- Full Text
- View/download PDF